Skip to content

Cardiac Output Monitoring Managing Intravenous Therapy (COMMIT) to Treat Emergency Department Severe Sepsis

Cardiac Output Monitoring Managing Intravenous Therapy (COMMIT) to Treat Emergency Department Severe Sepsis

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01484106
Acronym
COMMIT
Enrollment
65
Registered
2011-12-02
Start date
2011-11-30
Completion date
2014-08-31
Last updated
2021-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sepsis

Brief summary

The primary objective of this study is to test whether a fluid resuscitation protocol guided by non-invasive hemodynamic measures reduces the progression of organ dysfunction (defined by an increase in the Serial Organ Failure Assessment Score ≥ 1 over the first 72 hours) in sepsis patients presenting to the Emergency Department without evidence of shock.

Interventions

OTHERFluid Resuscitation

In the Treatment group, this information will be used in a specific 4-hour treatment algorithm to guide fluid administration that is summarized in Figure 1. The information provided by the NICOM in response to the fluid bolus will be used to assess whether the subject is fluid responsive (FR).

OTHERStandard of Care

Standard of Care

Sponsors

Cheetah Medical Inc.
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Adult patients \> 18 years with old suspected or confirmed infection 2. At least two of the following four criteria (SIRS): 1. Temperature \> 38 or \< 36o C 2. Heart rate \> 90 bpm 3. Respiratory rate \> 20 bpm or PaCO2\< 32 mmHg 4. White blood cell count \>12,000 or \<4,000 per mm3; or \>10% bandemia 3. Lactate ≥2.0 and ≤4.0 mMol/L 4. Enrollment within 6 hours of ED presentation within 2.5 hours of meeting eligibility criteria

Exclusion criteria

1. Age \< 18 years 2. On vasopressor therapy 3. Systolic blood pressure \< 90 mmHg 4. Received more than 3-liter crystalloid fluid prior to randomization 5. Patient presenting with pulmonary edema 6. Patient presenting with acute coronary syndrome 7. Patient presenting with new onset cardiac arrhythmia 8. Patient presenting with trauma, including burns 9. Patient requires immediate surgery 10. Patient presenting with stroke 11. Patient with end stage renal disease on renal replacement therapy 12. Patient with known pregnancy 13. Patient being treated with immunosuppressive therapy for organ transplant

Design outcomes

Primary

MeasureTime frameDescription
sequential organ failure assessment score increases by greater or equal to 1 point from the baseline score within 72 hours of study enrollment.72 hoursA patient will be considered to have progressive organ dysfunction if their Sequential Organ Failure Assessment (SOFA) score increases by ≥1 point from their baseline score within 72 hours of study enrollment.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026